Errik S. Knudsen
Affiliations: | Genetics | Thomas Jefferson University, Philadelphia, PA, United States |
Area:
Molecular Biology, Genetics, OncologyGoogle:
"Errik Knudsen"
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Pearson JD, Huang K, Pacal M, et al. (2021) Binary pan-cancer classes with distinct vulnerabilities defined by pro- or anti-cancer YAP/TEAD activity. Cancer Cell |
| Witkiewicz AK, Cox D, Knudsen ES. (2021) Correction: CDK4/6 inhibition provides a potent adjunct to Her2-targeted therapies in preclinical breast cancer models. Genes & Cancer. 12: 25-27 |
| Kumarasamy V, Vail P, Nambiar R, et al. (2020) Functional determinants of cell-cycle plasticity and sensitivity to CDK4/6 inhibition. Cancer Research |
| Franco J, Balaji U, Freinkman E, et al. (2020) Metabolic Reprogramming of Pancreatic Cancer Mediated by CDK4/6 Inhibition Elicits Unique Vulnerabilities. Cell Reports. 32: 107793 |
| Roberts PJ, Kumarasamy V, Witkiewicz AK, et al. (2020) Chemotherapy and CDK4/6 inhibitors: Unexpected bedfellows. Molecular Cancer Therapeutics |
| Knudsen ES, Kumarasamy V, Chung S, et al. (2020) Targeting dual signalling pathways in concert with immune checkpoints for the treatment of pancreatic cancer. Gut |
| Knudsen ES, Shapiro GI, Keyomarsi K. (2020) Selective CDK4/6 Inhibitors: Biologic Outcomes, Determinants of Sensitivity, Mechanisms of Resistance, Combinatorial Approaches, and Pharmacodynamic Biomarkers. American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting. 40: 115-126 |
| Knudsen ES, Nambiar R, Rosario SR, et al. (2020) Pan-cancer molecular analysis of the RB tumor suppressor pathway. Communications Biology. 3: 158 |
| Fountzilas C, Witkiewicz A, Muhitch J, et al. (2020) 103P Temporospatial heterogeneity in metastatic colorectal cancer (mCRC) Annals of Oncology. 31: S1458 |
| Kumarasamy V, Ruiz A, Nambiar R, et al. (2019) Chemotherapy impacts on the cellular response to CDK4/6 inhibition: distinct mechanisms of interaction and efficacy in models of pancreatic cancer. Oncogene |